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1. INTRODUCTION: 
 
 ABSTRACT: Prokaryotic kingdom constitutes the most abundant and omnipresent form of 
life. The constant contact of environmental bacteria with human beings, has allowed them to 
develop numerous mechanisms to protect themselves from the products generated by 
mankind. In this way, common and non-pathogenic bacteria, normally found in products of 
daily use, can present multiresistance to antibiotics. During our investigation, we will focus 
on bacteria obtained from different environmental samples, which have in common being 
innocuous and Gram-negative. It is suggested that all of them show resistance to antibiotics, 
the type of resistance that gives the presence of efflux pumps in the cell envelope. These 
pumps are responsible for expelling pathogenic compounds, from inside to outside the cell, 
before they can damage the bacteria. To test our hypotheses, it will be studied the minimal 
inhibitory concentration for the tetracycline and chloramphenicol antibiotics, as well as the 
bacterial membrane potential against the polymyxin B antibiotic. For the last procedure, the 
TPP+ marker will be used. 
 
The development of these experiments has allowed the obtainment of a clear result: a large 
part of the bacteria studied have the expected antibiotic resistance. It has also been proven 
that some of them are capable of resisting the presence of the three antibiotics used, proving 
to be multiresistant bacteria. However, a small number of experiments have been carried out, 
without taking into account all the bacteria obtained. The lack of comparative results prevents 
obtaining a broader view of the matter. Further studies, more detailed and taking into account 
the information obtained in this present, will be necessary to obtain more solid conclusions. 
 
 
1.1 Objectives. 
 
a) Test resistance to generic antibiotics of the strains obtained in environmental samples by 
the MIC method. 
 
b) Test resistance to generic antibiotics of the strains obtained in environmental samples by 
electrochemical experiments. 
 
c) Comparison of the results obtained in the two different procedures. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2. LITERATURE: 
 
 
2.1 Bacteria kingdom. 
 
In this research we will focus on bacterial strains found in environmental samples of different 
nature. All the bacteria studied here are non-pathogenic, mostly Gram-negative, having in 
common their multidrug resistance using efflux pumps. 
 
Bacteria are prokaryotic microorganisms that have a micrometric size and various forms, 
including filaments, cocci, bacilli, vibrios and spirals. Bacteria are prokaryotic cells, so, unlike 
eukaryotes, they do not have a defined nucleus or, in general, any internal membranous organelle. 
They usually have a cell wall composed of peptidoglycan. Many bacteria are mobile,  having 
flagella or other displacement systems.(1)  
Bacteria are the most abundant organisms on our planet. They are ubiquitous, found in all 
terrestrial and aquatic habitats. Some bacteria can even survive in the extreme conditions of outer 
space.(2) In our case, we are going to study bacterial strains found in environmental samples. These 
are non-pathogenic bacteria that can be found in products and utensils that we use in our daily 
lives.  
 
One of the most important features of bacteria is their surface. The complex conformation of its 
cell wall has allowed them to become the most efficient forms of life. The cell wall is considered 
to be the principal stress-bearing structure and surrounds the  bacterial cytoplasmic membrane.(3) 
 
 
2.2 Gram-negative bacteria. 
 
Gram stain is a staining method used to distinguish and classify bacterial species into two large 
groups according to their reaction to various dyes: Gram-negative and Gram-positive bacteria. It 
differentiates bacteria by the chemical and physical properties of their cell walls. The Gram stain 
is usually the first step in the preliminary identification of a bacterial organism.(4) 
 
In microbiology, Gram-negative bacteria are those that do not stain violet by the Gram stain dye 
called crystal violet, and they do so in a light pink color: hence their name, negative for Gram 
dye. This characteristic is intimately linked to the dimeric structure of their distinctive cellular 
envelope, since it has a double cellular membrane. Between their two bilipid membranes a thin 
cell wall of peptidoglycan is placed, whereas Gram-positive bacteria have only one lipid 
membrane and  a much thicker peptidoglycan wall. Because of having a thin wall, the Gram-
negative bacteria do not retain the dye during Gram's stain.(5) 
 
The cellular surface of Gram-negative bacteria is composed of a cytoplasmic membrane (inner 
membrane), a thin cell wall of peptidoglycan and an outer membrane that lines the cell wall of 
these bacteria. Between the internal cytoplasmic membrane and the outer membrane is located 
the termed periplasmic space, filled with a substance called periplasm, which contains crucial 
enzymes for their nutrition. (5)(6) 
 
The outer membrane contains various proteins; among them, porins or channel proteins that allow 
the passage of certain substances. It also has a component called lipopolysaccharide (LPS), which 
is formed by three regions: the polysaccharide O (antigen), a central polysaccharide structure 
(core polysaccharide) and the lipid A (endotoxin). The lipopolysaccharide contains a 
thermostable toxin that is released when the Gram-negative bacteria breaks. 
 
Gram-negative bacteria may have a S layer that rests directly on the outer membrane and not on 
the peptidoglycan wall, as in the Gram-positive ones. If they have flagella, they have four support 
rings instead of the two from Gram-positive bacteria. They do not present teichoic acids or 
lipoteichoic acids, typical of Gram-positive ones. The lipoproteins are bound to the nucleus of 
polysaccharides, while the Gram-positive bacteria  do not present that type of proteins. (6) 
 
The mentioned outer membrane protects bacteria from various antibiotics, dyes and detergents 
that would normally damage the inner membrane or cell wall of peptidoglycan. The outer 
membrane gives these bacteria resistance to lysozyme and penicillin.(7) 
 
 
2.3 Antibiotics. 
 
Throughout this investigation, several antibiotics will be used, they will be explained in this 
section. An antibiotic is a chemical produced by a living being or synthetic derivative, that either 
kills or prevents the growth of mainly pathogenic microorganisms. The principal target are 
pathogenic bacteria so they are usually known as "antibacterial".(8) 
2.3.1 Chloramphenicol. 
Chloramphenicol (CHPC, D (-) threo-2-dichloroacetamido-1-p-nitrophenyl-1,3-propanediol) is 
part of the protein synthesis inhibitors. This kind of antibiotics are able to inhibit some steps or 
the whole protein synthesis process.(9) This drug is a broad-spectrum antibiotic that acts stopping 
the production of bacterial proteins. It is a bacteriostatic agent since it does not directly produce 
the death of the bacteria but prevents its growth.(10) This drug, thanks to its extremely lipid-
solubility is able to penetrate into the cell by facilitated diffusion. Afterwards it binds to the 50S 
fraction of the bacterial ribosome preventing the transpeptidation between the amino acids of the 
peptide chain, thus preventing elongation of the growing chain. Chloramphenicol is capable of 
inhibiting the activity of the enzyme peptidyl transferase, preventing the binding of the substrate 
in the ribosome. In this way this antibiotic inhibits the total protein synthesis.(11) 
 
Figure 1: Chloramphenicol structure. National Center for Biotechnology Information. PubChem 
Database. 
Studying its structure, it is considered that this compound has two asymmetric carbons, giving 
rise to four possible stereoisomers. The natural isomer (D (-) threo), the L (+) threo isomer with 
a very reduced activity and finally two isomers are biologically inactive. 
 
Some experiments have shown that the stereochemical configuration on carbon 1 is essential for 
any biological activity. It is also known that the structure of the propanediol half is critical for the 
antibiotic activity being its side chain considered the specific pharmacodynamic portion of the 
molecule, the hydrogen atoms on carbon 2 and 3 and the amide nitrogen are the attachment points 
with the enzyme. In the acetamide side chain, if the free hydrogen on the nitrogen atom is 
replaced, all antibiotic activity is lost because of being needed for the interaction with the polar 
groups of the proteins. Consequently, certain features of the chloramphenicol molecule seem 
important for its antibacterial function.(12) 
 
2.3.2 Tetracycline. 
 
The tetracyclines are also part of the protein synthesis inhibitors and consist of eight related 
broad-spectrum antibiotics. They contain a naphthalene ring of four atoms and are chemical 
derivatives of the polycyclic naphthalenecarboxamide, tetracyclic nucleus, from which the name 
of the group derives.(13) They act mainly as bacteriostats at usual doses, although they are 
bactericidal at high doses, generally toxic ones. They use several mechanisms: decoupling 
oxidative phosphorylation, inhibiting protein synthesis and even, in some cases, altering the 
cytoplasmic membrane.(10) 
Nevertheless, these antibiotics are mostly known for their action against protein synthesis. To 
carry out this job, they act at the bacterial ribosome level, but for having access to it, their passive 
diffusion through the outer cell membrane through the hydrophilic pores is required, needing a 
second energy-dependent process that actively transports all the tetracyclines through the internal 
cytoplasmic membrane.(14) Once they are inside the bacteria, tetracyclines inhibit protein 
synthesis by binding to the A-site of the ribosomal 30S subunit, they prevent access of the 
aminoacyl-tRNA to the A-site of the mRNA-ribosome complex, and this results in the non-
addition of amino acids to the growing peptide chain. Thus without the sequential attachment of 
the tRNA at the A-site, protein biosynthesis cannot occur.(15) 
Considering their chemical structure, tetracyclines include a linear fused tetracyclic nucleus (rings 
designated A, B, C, and D) with various functional groups attached to it. The simplest tetracycline 
to display detectable antibacterial activity is 6-deoxy-6-demethyltetracycline (Figure 2). 
 
Figure 2: The simplest tetracycline molecule(15) 
Firstly, this group of antibiotics is characterized by a strong chelating action and both their 
antimicrobial and pharmacokinetic properties depend on this property. Important antibacterial 
features among the tetracyclines are mainly maintenance of the linear fused tetracycle, and 
conservation of the keto-enol system (positions 11, 12, and 12a) in proximity to the phenolic D 
ring. It is proven that any kind of substitution at positions 1, 3, 4a, 10, 11, or 12 affects negatively 
their antibacterial activity, a considerable number of other substitutions at different positions on 
the B, C, and D rings are, however, tolerated.(16) 
 
 
 
 
 
2.3.3 Polymyxin. 
Polymyxin is included in the cell membrane inhibition activity antibiotics. These antibiotics 
disorganize the structure or inhibit the normal function of bacterial membranes. There are 5 
different types of polymyxins: A, B, C, D and E, but only types B and E are used as 
chemotherapeutic drugs. The B type is formed by two different molecules, B1 and B2. They are 
all part of a broader class of molecules called nonribosomal peptides.(17) 
 
Figure 3: Chemical structure of Polymyxin B(18) 
The chemical structure of polymyxin consists of basic cyclic decapeptides, with a high content of 
diaminobutyric acid, with dextrorotatory and levorotatory amino acids, with a fatty acid, usually 
methyloctanoic acid. Polymyxins have a spectrum of activity limited almost exclusively to Gram-
negative bacilli.(18) 
 
Polymyxins are all cationic detergent-type antibiotics. They are amphipathic molecules with 
surface activity. Interacting in a potent way with phospholipids, they break the structure of cell 
membranes. The permeability of the bacterial membrane changes immediately upon contact with 
this drug.(19) 
 
The chemical composition of polymyxin is crucial for its antibacterial activity. The different 
polymyxin molecules have in common two hydrophobic domains separated by polar and cationic 
residues. The three-dimensional configuration gives it its amphipathic character. Its hydrophobic 
domains are responsible to interact with the lipopolysaccharides of the outer membrane of Gram-
negative bacteria and have an important role in causing the membrane damage.(20) 
 
When it is in solution, part of the molecule is ionized, presenting a positive partial charge, an 
important characteristic for its interaction with the negatively charged phosphate groups of lipid 
A of the LPS of the Gram-negative outer membrane. The electrostatic interaction between the 
positively charged residues and the negatively charged lipid A phosphates causes the 
displacement of divalent cations (Ca2+ and Mg2+) that normally function to bridge and stabilize 
the LPS outer membrane monolayer.(21) 
 
Due to the hydrophobic and electrostatic interactions, the outer membrane of the bacteria is de-
sized. Polymyxin is able to replace the formation of LPS by the formation of channels and pores, 
permeating the outer membrane it allows the passage of higher concentrations of polymyxin. In 
this way, this antibiotic breaks the physical integrity of the bacterial membrane leading to its 
death.(22) 
 
 
2.4 Antibiotic resistance: Efflux pumps. 
 
Due to their continuous contact with humans, the strains studied in this research have been able 
to develop mechanisms to protect themselves against compounds that we constantly utilize, such 
as antibiotics. 
 
Antibiotic resistance is the ability of a microorganism to resist the effects of a certain antibiotic. 
It is a subset of AMR, antimicrobial resistance, the ability of a microbe to resist the effects of 
drugs that once were able to kill them.(20) Resistance occurs naturally by natural selection through 
mutations produced by chance. The antibiotic, when it contacts with a bacterial population, allows 
only the proliferation of those bacteria that have that natural mutation that cancels the action of 
the antibiotic. Once this genetic information is created, the bacteria can transmit the new 
resistance genes through horizontal transfer by exchange of plasmids. If a bacteria carries several 
resistance genes, it is called multi-resistant as those studied in this research.(23)  
 
Gram-negative bacteria have a broad arsenal of antibiotic resistance mechanisms. These 
resistance mechanisms could be summarized in four categories: enzymatic modification, changes 
in the permeability of the outer membrane, alterations in the site of action and efflux pumps.(24) 
Efflux systems are energy-dependent mechanisms that act by pushing out harmful substances 
through specific efflux pumps.(25) Some efflux systems are drug-specific so they only excrete one 
drug or one class of drugs; whereas others may accommodate multiple drugs, pumping out a wide 
range of compounds. Specifically, efflux pumps are efflux systems formed by protean active 
transporters that are found in the cytoplasmic membrane.(26) 
 
Active efflux systems have been seen to cause drug resistance in Gram-negative bacteria. The 
majority of Gram-negative bacterial multidrug efflux pumps are completely different in their 
construction in comparison to the traditional ones. They cross both the cytoplasmic (inner) and 
outer membranes by using three protein components which facilitates direct passage of the 
substrate into the external medium.(27) This tripartite efflux system is composed by a transporter 
located in the inner membrane, an outer membrane channel and a periplasmic accessory protein. 
It is considered that the outer membrane barriers and the multicomponent efflux systems act 
synergistically to lower the cytoplasmic and even the periplasmic concentrations of antibiotics.(28) 
 
2.4.1 ABC transporters.  
 
The ATP-Binding Cassette (ABC) transporters are conserved from bacteria to humans and are 
able to pump out a wide range of substrate using the energy produced by ATP hydrolysis.(29) In 
Gram-negative organisms, ABC transporters can mediate secretion through both membranes 
simultaneously, bypassing the periplasmic space. This secretion pathway involves two additional 
accessory proteins as was explained. 
 
Functional ABC pumps consist of two transmembrane domains (TMDs) responsible for substrate 
recognition and its transport, and two cytosolic nucleotide binding domains (NBDs), also known 
as ATP-binding cassettes, where ATP is hydrolyzed.(30) Despite the large diversity of the transport 
substrates, the sequences of the ABC components are remarkably conserved. Being the most 
conserved structure the one that corresponds to NBD due to its common function. (31) 
 
Each NBD can be divided into two domains: a larger RecA-like subdomain consisting of two β-
sheets and six α-helices which corresponds to the catalytic core and a smaller helical subdomain 
formed by three to four α-helices. Several conserved sequence motifs, such as the Walker A and 
Walker B motifs that are found in many ATPases, can be identified here. In spite of the fact that 
the helical subdomain is specific to the ABC. (32) ATP binds to the catalytic subdomain, and its γ-
phosphate is positioned close to the edge of one of the β-sheets where it interacts with several 
residues. The Walker A motif, also known as the P loop, forms a loop that binds to the phosphates 
of ATP or ADP. The main responsible for the hydrolysis of the ATP is the Walker B motif.(33) 
Inside the helical subdomain we can find a unique structure, the called signature motif, also 
known as the LSGGQ motif, linker peptide, or C motif. It has been used as the “signature” to 
identify ABC transporters and is the only major conserved motif that does not contact nucleotide 
in the monomer structure. (34)  
 
Figure 4: Mechanistic models for ABC transporters.(35) 
ATP binding and hydrolysis are coupled to conformational changes in the MSDs that mediate the 
transit of substrates across the membrane. This ATP switch mechanism for ABC transporters 
takes place when a nucleotide-driven interaction of the NBDs causes reorientation of the TMDs. 
(35) This process is mediated by two different sets of transmembrane helix interactions. The 
outward-facing conformation is caused by ATP binding and reflects the ATP-bound state, with 
the two transmembrane domains forming a central cavity that is thought to be the drug 
translocation pathway. The inward-facing conformation is promoted by dissociation of the 
hydrolysis products (ADP and phosphate) and shows the substrate-binding site accessible again 
from the cell interior. (36)  
 
2.4.2 MATE pumps. 
 
The Multi antimicrobial extrusion protein family is the most recently described efflux pump 
within the five multidrug efflux transporter families. (37) The common structure within the 
members of the MATE family es a 12 transmembrane hydrophobic helix topology with an internal 
twofold sequence similarity reflected in the tertiary disposition. (38) Structures also display an 
external-facing cavity, extending approximately halfway across the membrane. This family 
confers resistance to multiple cationic toxic agents acting as H+- or Na+-antiporters. Almost all 
MATE-family transporters can recognize fluoroquinolones as transport substrates, such as 
norfloxacin. Although it presents a smaller amount of possible substrates than the RND 
transporters this family is still considered a multidrug efflux transporter. (39)  
 
Figure 5: Proposed antiport mechanism.(39) 
2.4.3 MFS pumps. 
 
The major facilitator superfamily forms the largest multidrug efflux transporters family. This 
family is composed of antiporter transporters with tripartite structure (as explained) in Gram-
negative bacteria kind. Uniporters and symporters can also be found within this family. They are 
responsible of the transport of a wide range of structurally diverse low molecular weight 
substrates, being lipophilic cations the most remarkable ones.(33) 
 
These pumps work using the potential produced by some electrochemical process. Most of them 
use the energy generated by the proton gradient. Their stoichiometry is 1:1, a substance expelled 
by each proton used. In this way, MFS pumps are the most energy efficient pumps that use 
protons. Structurally, these transporters are constituted by twelve or fourteen transmembrane 
helices of variable conformation that constitute a compact structure with four of them facing away 
from the interior. The remaining transmembrane helices form a central cavity with hydrophobic 
conserved residues.(40) 
 
 
 
 
 
 
 
 
 
 
Figure 6:Schematic diagram to illustrate the alternating access mechanism for MFS transporters.(41) 
It is proposed that the substrate binding site faces one side of the membrane when it is resting and 
it orients itself via a conformational change once the substrate appears, the binding site is able to 
face the other side of the membrane in order to facilitate the transport.(41) 
 
 
 
 
 
2.4.4 SMR transporters. 
 
The small multidrug resistance family are the smallest in terms of length at just 100–120 amino 
acids can transport many quaternary ammonium compounds (QAC) in addition to other lipophilic 
cations.(29) It functions as an antiparallel dimer, with a fixed stoichiometry of two protons 
exchanged per substrate molecule, meaning that transport of monovalent cations results in net 
charge movement (electrogenic), whereas transport of divalent cations does not (electroneutral). 
These proteins are believed to span the cytoplasmic membrane as four transmembrane α-helices 
with short hydrophilic loops making them very hydrophobic, a characteristic that permits their 
solubilization in organic solvents Structural plasticity and flexibility is decisive in its multidrug 
recognition and transport.(42) 
 
2.4.5 RND transporters. 
 
The resistance-nodulation-cell division superfamily in Gram-negative bacteria are found in the 
inner membrane and work together with two other proteins forming a tripartite complex that 
extends through both bacterial membranes through the periplasmic space. These transporters have 
membrane-spanning domains and a very large periplasmic domain.(33) 
 
The most commonly studied members of this family are AcrB (E. coli) and MexB (Pseudomonas 
aeruginosa). This pumps work like molecular machines, where their inner membrane protein 
associates with a periplasmic adaptor protein and a long helical tunnel protein to cross the double 
membrane of the Gram-negative bacteria and effect the efflux of toxic compounds directly to the 
extracellular environment.(28) RND transporters are able to capture even those substrates that 
cannot permeate across the cytoplasmic membrane suggesting that the capture can occur from the 
periplasm. It was also suggested that the capture occurs from the cytoplasmic 
membrane/periplasm interface, because most substrates contain a sizable hydrophobic domain. 
Because of that it is proven that much of the substrate specificity is determined by their 
periplasmic domains. This family presents a fairly broad spectrum of substrates including 
antibacterial and chemotherapeutic agents.(43) 
 
Figure 7: Tripartite structure of RND transporters. 
 
The transport through these pumps takes place thanks to the protonic force since they are treated 
as proton/drug antiporters. The transfer of protons is carried out by three charged amino acids 
present in the fourth and tenth transmembrane domain. The transmembrane domains have 
conserved structures and practically have the same residues, including the triplet involved in 
proton translocation.(44) 
 
 
3. MATERIALS AND METHODS: 
 
 
3.1. Materials. 
 
3.1.1 Strains. 
 
Bacteria used in this study were found in diverse environmental samples and are listed in table 1. 
It is worth mentioning that those discovered in cosmetic products were obtained in previously 
unsealed and used products. As control groups, there will be used Pseudomonas aeruginosa wild-
TYPE bacteria (PA01) and MUTANT Pseudomonas aeruginosa bacteria (PT629). 
 
Table 1 A: Bacteria strains.(45) 
Nº Code name Bacterial type Sample location  
1. F2 Pseudomonas 
rhodesiae 
Livestock Farm 
2. F3 Pseudomonas spp. Livestock Farm 
3. F4 Pseudomonas spp. Livestock Farm 
4. F5 Pseudomonas spp. Livestock Farm 
5. F6 Pseudomonas spp. Livestock Farm 
6. F7 Pseudomonas spp. Livestock Farm 
7. F8 Pseudomonas 
koreensis 
Livestock Farm 
8. F9 Pseudomonas 
rhodesiae 
Livestock Farm 
9. PT629 Pseudomonas 
aeruginosa 
University’s 
collection 
10.  F10 Pseudomonas 
koreensis 
Livestock Farm 
 
Table 1 B:  Bacteria strains.(45) 
1. K3 Bacilus spp. Essence Eyebrow 
Shade 
2. K5 Escherichia coli Essence Eyebrow 
Shade 
3. K6 Escherichia coli Loreal Foundation 
4. K7 Escherichia coli Loreal Foundation 
5. K8 Escherichia coli Essence Lip Pencil 
6. Q10 Pseudomonas spp. Essence Lip Pencil 
7. B3 Escherichia coli Deodorant "Old 
Spice Champion" 
cover 
8. PA01 Pseudomonas 
aeruginosa 
University’s 
collection 
9.  K1 Bacilus spp. Essence Eyebrow 
Shade 
10. B2 Eschericia coli "Sensodyne" 
toothpaste 
 
 
3.1.2 Culture media. 
 
The culture media used are sterilized in an autoclave for 15 minutes at 121 ⁰ C and prepared with 
distilled water. The detailed preparation will be explained in section 3.4.1. The composition of 
the media used is presented in table 2. 
 
Table 2: Luria-Bertani (LB) Broth and Agar composition (Lennox). 
 LB Agar  LB Broth 
Tryptone 10 g/L 10 g/L 
Yeast extract 5 g/L 5 g/L 
Sodium chloride (NaCl) 5 g/L 5 g/L 
Agar 15 g/L - 
 
3.1.3 Reagents. Antibiotics. 
 
• Chemical reagents: 
o TRIS Buffer. (“ROTH”) 100mM at pH 8 
o EDTA, ethylenediaminetetraacetic acid. (“ROTH”) 100 mg/mL 
o Na2S2O4, sodium dithionite. (“ROTH”) 
• Antibiotics: 
o Chloramphenicol. (“Fluka”) 40 mg/mL 
o Tetracycline. (“ROTH”) 50 mg/mL 
o Polymyxin B. (“Sigma-Aldrich”) 50 mg/mL 
 
3.1.4 Laboratory equipment. 
 
• Centrifuge (“Allegra 64R Centrifuge”) 
• Shaking incubator (“Environmental Shaker-Incubator ES-20”) 
• Autoclave (“LABOKLAV 25”) 
• Laminar flow cabinet (“Bioair”) 
• Spectrophotometer (“Amersham”) 
• Microplate Reader (“Tecan Machine”) 
 
 
3.2 Methods. 
 
3.2.1 Preparations prior to the experiments. 
 
a) Agar plates preparation:  
First of all, the dehydrated components of the medium have to be dissolved in distilled water, 
following the instructions of the manufacturer. While the medium contains a solidifying agent 
(agar-agar) it is necessary to heat the preparation until boiling it, stirring from time to time. Once 
it is dissolved, the medium must be sterilized to prevent the growth of contaminants. For solid 
media in plate we have to cover the flask with aluminum foil and carry out sterilization to the 
autoclave (121 ºC) for 15-20 minutes. Once sterile, we have to distribute in sterile petri dishes 
inside of a laminar flow cabinet in order to prevent possible contamination and leave to rest to 
solidify. It is also advisable to use the UV-G germicidal lamp of the cabinet for the same purpose. 
We will culture our strains from the frozen stocks using the “streaking” technique. 
 
 
b) LB broth preparation:  
A similar procedure will be followed to dissolve the LB broth. According to the manufacturer’s 
instructions, the volume needed will be prepared with the dehydrated components and distilled 
water. Then, the solution will be sterilized by autoclavation.  
 
c) Over-night culture:  
Grown colonies will be taken using a sterile plastic loop and will be mixed in a tube with 5 mL 
of also sterile LB broth previously prepared. This solution will be kept in a shaking incubator (30 
ºC and 220 rpm) for at least 16 hours. 
 
d) Day culture:  
A certain volume of the overnight culture will be taken and passed to 50 mL LB broth placed in 
an Erlenmeyer flask. The absorbance of the resulting culture will be 0.1. This new culture will be 
stored in a shaking incubator (220 rpm at 30ºC) until its absorbance reaches the required value 
for our experiment, that is to say, 1.2.  
 
3.2.2. MIC Method: Dilution method to determine the MIC of antimicrobial substances 
using 96-well microplates. 
 
The minimal inhibitory concentration (MIC), in microbiology, is the lowest concentration of an 
antimicrobial agent that inhibits the growth of a microorganism after its incubation. The minimum 
inhibitory concentrations can be determined by broth microdilution methods, as it is in our case.(46)  
A transparent polystyrene microplate with 96 wells, 12 columns (1-12) and 8 rows (A-G) is used. 
Our final volume will be 200 μL/well, using row G as positive control (bacterial culture is added 
but not antibiotic) and H as negative control (only sterile LB medium). 
This procedure can be divided in the following steps:(47) 
 
a) Preparation of inoculum: 
1) Preparation of overnight cultures of the strains of study as explained at 3.2.1 c section. 
2) After approximately 16 hours, check of the OD600 with a spectrophotometer. 
Knowing that 1 OD600 is equal to 8x108 CFU/mL, our bacterial concentration will be 
calculated. 
3) Dilution of the bacterial solution with LB Broth to obtain a 5x105 
CFU/mL suspension. 
 
b) Inoculation, incubation and reading: 
1) Addition of 180 µL of LB Broth in every well of the microplate using a multichannel 
pipette. 
2) Addition of 20 µL of antibiotic (tetracycline or chloramphenicol) in the A row. 
3) Addition of 200 µL of LB Broth in the first row and carry out a serial dilution. 
Mixture and transference of the volume to the next line. The procedure has to be 
repeated until the F row. The 200 µL added has to be removed after the last mixture. 
4) Addition of the bacterial volume prepared at a section from first row to G row. 
5) Incubation in a 30ºC incubator for 24-30 hours. 
6) Spectrophotometer reading on a microplate reader at 612 nm. 
 
 
 
 
 
3.2.3 TPP+ measurement: Electrochemical method. 
 
For the study of the action of antimicrobial agents, the measurement of the bacterial membrane 
permeability and potential are crucial. It is a way to evaluate the ability of these antimicrobial 
agents to generate channels or, more generally, to increase permeability and to abolish membrane 
potential in bacterial cytoplasmic membranes in situ.(48) Lipophilic cation TPP+ or 
tetraphenylphosphonium is a membrane potential probe as it passes through the cytoplasmic 
membrane and accumulates in the cytosol depending on the potential (inside negative) formed in 
the membrane. Therefore, if an antibiotic has the ability to induce membrane depolarization, it 
will cause an efflux out of the accumulated TPP+.(49)  
Preparation of overnight culture of the strains (3.2.1 c section) with a half hour interval between 
each other.(50) 
1. Preparation of day culture as explained in 3.2.1 d section. 
2. Preparation and calibration of the equipment: Immersion of the reference electrode and 
the TPP+ electrode in 5 mL of TRIS buffer. The solution is contained in termasized glass 
buckets, aerated using magnetic stirrers and maintained at a constant temperature of 30ºC. 
3. The LabChart program from a computer is connected to the equipment and prepared to 
measure the ion concentrations during the experiment.  
4. The bacterial suspension from the day culture will be centrifugated (10 min, 4ºC and 
3000xG) once the OD is 1.2 and the supernatant will be decanted. The cells are 
resuspended in 100 μL of TRIS buffer.  
5. Measurement of the sample absorbance in order to calculate the volume of suspension 
needed to obtain an OD of 3 in the bucket.  
6. The experiment can get started according to the following schedule: 
- Minute 2: 5 μL of TPP+ dissolved in distilled water are added. 
- Minute 4: Another 10 μL are added. 
- Minute 7: The volume of cell culture calculated above is added.  
- Minute 9: 4 μL of EDTA are added. 
- Minute 12: 5 μL of polymyxin (25 mg/mL) are added. 
- Minute 14: A small amount of a reducing agent (Na2S2O4) is added to bind to the 
rest of the oxygen in the medium and thus end the test. 
7. The results are obtained in txt format and, using the SigmaPlot program, they can be 
studied and converted into graphs. 
3.2.4 Statistical methods and analysis of results. 
 
All computationally obtained results are processed and refined using the SigmaPlot program 
(electrochemical experiments) and the MS Excel software (MIC experiments). Both programs 
permit the obtainment of graphic results, in order to facilitate the study of the antibiotic effect 
over time. Each experiment has been repeated three times, thus being able to standardize the 
results. Basic statistical tools such as arithmetic mean or standard deviation have been used.  
Being, respectively: 
 
                
 
 
4. RESULTS: 
 
 
4.1 MIC experiment. 
 
This experiment is developed to study the effect of different concentrations of tetracycline and 
chloramphenicol antibiotics on the growth of our strains under study. A range of concentrations 
of 0 to 2.5 μg / mL will be used in both antibiotics and the spectrophotometric results obtained in 
the form of an excel document will be refined and studied graphically: 
 
a) Tetracycline resistance: 
 
 
Figure 8: MIC method of K5, F10 and K8 strains using tetracycline. 
According to the Figure 8, the strains studied together in this assay show a fairly similar behavior 
of tetracycline sensitivity. The three of them suffer the completely growth suppression pretty 
soon, once the antibiotic reaches the value 0.313 μg/mL value in the case of K5 and F10, and 
0.625 μg/mL for K8. 
 
 
 
Figure 9: MIC method of F6, K1, F7 and F5 strains using tetracycline. 
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In the case of the graph of Figure 9, it can be observed that the four strains suffer the increase in 
antibiotic concentration in a not homogeneous or similar way. The growth of bacteria F6 and K1 
is suppressed when the tetracycline concentration is 2.5 μg/mL. In the case of bacteria F5 and F7, 
their growth slows down partially but they manage to survive even at the maximum concentration 
of 2.5 μg/mL. 
 
 
        
Figure 10: MIC method of F8, F4 and K10 strains using tetracycline. 
In Figure 10, two different responses can be observed. F8 and F4 have a clear resistance to the 
antibiotic, and may even increase the population at higher concentrations, while the K10 strain is 
affected, stopping reproducing at the maximum concentration (2.5 μg / mL). 
 
 
                                
Figure 11: MIC method of K1, F3, F10, F2 and B3 strains using tetracycline. 
In Figure 11, four strains of similar behavior and one strain that differs are distinguished. Only a 
clear decrease in the bacterial population can be observed in the case of strain F10 whose growth 
is completely suppressed when the concentration is 2.5 μg/mL. For the rest of strains, K1, F2, F3 
and B3, no clear antibacterial effect is observed, so it can be said that they are resistant bacteria. 
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b) Chloranphenicol resistance: 
 
 
Figure 12: MIC method of K10, F6, F5 and F4 strains using chloramphenicol. 
A clear difference can be observed between strains F6 and K10 versus F5 and F4 in Figure 12. 
The first two, show a sensitivity to the antibiotic, inhibiting their growth once the concentration 
of chloramphenicol reaches the maximum used (2.5 μg / mL). On the other hand, strains F5 and 
F4 show resistance to this antibiotic, maintaining a mainly constant growth despite the increasing 
concentration of antibiotic. 
 
 
 
Figure 13: MIC method of K3, F10 and B3 strains using chloramphenicol. 
 
In the case of the strains treated in the test of Figure 13, we can defend that they are bacteria 
sensitive to the antibiotic but with a higher MIC. The inhibition of these bacteria (K3, F10, B3) 
occurs when the concentration of chloramphenicol is 2.5 μg/mL. A greater sensitivity can be 
observed with F10 and B3 because their inhibition is more drastic than in the case of K3. 
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Figure 14: MIC method of K6, F3, K7 and K3 strains using chloramphenicol. 
According to Figure 14, there are again two distinguishable behaviors. The inhibition for K6, K7 
and K3 bacteria occurs when the concentration of antibiotics reaches the maximum of 2.5 μg/mL, 
the growth of bacteria in this concentration of chloramphenicol is suppressed. On the other hand, 
the growth of F3 bacteria is not affected by the presence of this antibiotic. A small initial decrease 
can be observed but after it, the bacterial population remains constant even at 2.5 μg/mL of 
chloramphenicol. 
 
 
 
             Figure 15: MIC method of F8, PT629 and F9 strains using chloramphenicol. 
In this experiment we used the stock strain PT629 (check table 1A), corresponding to 
Pseudomonas aeruginosa. PT629 together with F9 present a clear resistance to this antibiotic, 
being able to use it as carbon source. For the F8 strain, the growth inhibition is gradual but 
constant, completely suppressed at 2 μg/mL of chloramphenicol. 
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Figure 16: MIC method of K1 PA01 and K9 strains using tetracycline. 
In this assay, although the K1 strain has a much lower initial population, the three bacteria studied 
behave similarly. In this case, stock strain PA01 (Pseudomonas aeruginosa wildtype) was used. 
PA01 and K1 are inhibited once the antibiotic concentration reaches the value of 2 μg/mL. Strain 
K9 is more clearly suppressed when the concentration reaches the maximum used, 2.5 μg/mL, 
even though it is already affected at the concentration of 2. However, for K9 and PA01 we can 
observe a more pronounced decrease than for K1. 
 
After this resistance testing of several of our bacterial strains (listed in table 1A and 1B) it has 
been possible to prove, as a rule, a greater resistance to the chloramphenicol and tetracycline 
antibiotics in those bacteria from the farm samples; requiring the maximum concentration to 
suppress its growth and, sometimes, not even at such concentration is inhibited. It is also 
remarkable that when studying the strains from University's collection, the mutant strain shows 
resistance while the wildtype is clearly antibiotic sensitive. 
 
 
4.2. TPP+ measurement.  
These experiments have been performed using the antibiotic Polymyxin B (prepared at a 
concentration of 2.5 mg/mL) and buffer TRIS at 100 mM and pH 8; at a constant temperature of 
30 ° C. Due to the fact that we are working with Gram-negative bacteria, it is necessary to treat 
them previously with the EDTA agent to allow the TPP+ entrance. The concentration of the ion 
in the medium will allow us to elucidate the state of the membrane potential of our bacteria 
throughout the process. 
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 Figure 17: Bacterial  membrane potential assay using TPP+in F3 strain. 
Graph A (Figure 15) shows the graphic representation of the results obtained for the F3 strain. 
The concentrations of TPP+ ion will be analyzed after adding Polymyxin B 9 times. Some 
membrane damage begins to be recognized when the concentration of the antibiotic is 0.02 
mg/mL as it starts to expel TPP+. To obtain a total expulsion of the ion, a concentration of 0.45 
mg/mL is required. 
 
 
Figure 18: Bacterial membrane potential assay using TPP+in F9 strain. 
 
12 inoculations of the antibiotic were necessary for the F9 strain. When the concentration of 
polymyxin B is 0.035 mg/mL, the bacterium starts to expel TPP+, getting to expel it completely 
once the concentration reaches the value of 0.06 mg/mL.  
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 Figure 19: Bacterial membrane potential assay using TPP+in F10 strain. 
For the F10 strain, 6 inocula of polymyxin B were required, finding the depolarization point when 
the antibiotic concentration is 0.03 mg/mL. The bacterium begins to expel TPP+ when the 
polymyxin is at 0.015 mg/mL concentration. 
 
Figure 20: Bacterial membrane potential assay using TPP+ in F8 strain. 
Finally, for the F8 strain only a single addition of polymyxin B was needed. The complete 
depolarization occurs with a concentration of 0.005 mg/mL, demonstrating that we are facing a 
bacterium sensitive to the antibiotic used. 
 
As it was possible to verify after obtaining the results for the MIC experiment, the bacteria 
obtained in the farms show a more noticeable resistance to polymyxin B, having to inoculate said 
antibiotic a greater number of times. 
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5. CONCLUSION: 
 
a) After the results obtained in the MIC experiment, it has been possible to verify a clear resistance 
for the antibiotics chloramphenicol and tetracycline. Ten of the samples studied survived all the 
antibiotic concentrations used, and could not be found their minimal inhibitory concentration. 
Most of the resistant strains are those obtained in the farm, being also those that present a stronger 
resistance. 
 
b) Electrochemical experiments enable us to observe how many inocula of the antibiotic were 
necessary to completely damage the bacterial membrane. Except for the strain F8 that has been 
found to be sensitive to the antibiotic used, the rest of the strains required numerous inocula to be 
affected, again demonstrating resistance this time against polymyxin B. 
 
c) It was confirmed that several of our strains are multiresistant due to the fact that they are not 
inhibited by any of the three antibiotics used here. Of the twenty strains studied, we have observed 
a generalized sensitivity for the case of bacteria K1 or F6, however F8 presents sensitivity for 
polymyxin B but not for tetracycline, and vice versa with F10 and chloramphenicol/polymyxin 
B. Moreover, the same strains have not been studied the same against the three different 
antibiotics, hence the results for the three antibiotics for each bacterium cannot be compared. 
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